Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QMS Medical Allied ServicesNSE:QMSMEDI +5.00%69 EV-to-EBITDA is 14.55 as of Sep. 21, 2026, which is 24% above its 10-year median of 11.77. GuruFocus rates NSE:QMSMEDI with a GF Score™ of 69/100 and a GF Value™ of ₹85.48 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 532 Medical Devices & Instruments companies, QMS Medical Allied Services ranks worse than 54.32% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, QMS Medical Allied Services's enterprise value is ₹4,206 Mil.
QMS Medical Allied Services's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₹289 Mil. Therefore, QMS Medical Allied Services's EV-to-EBITDA for today is 14.55.
The historical rank and industry rank for QMS Medical Allied Services's EV-to-EBITDA or its related term are showing as below:
NSE:QMSMEDI'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.4 Med: 11.77 Max: 84.01
Current: 14.55
During the past 5 years, the highest EV-to-EBITDA of QMS Medical Allied Services was 84.01. The lowest was 3.40. And the median was 11.77.
NSE:QMSMEDI's EV-to-EBITDA is ranked worse than 54.32% of 532
companies
in the Medical Devices & Instruments industry
Industry Median: 13.14
vs NSE:QMSMEDI: 14.55
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
QMS Medical Allied Services (NSE:QMSMEDI) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
QMS Medical Allied Services's PE Ratio (TTM) for today is calculated as:
QMS Medical Allied Services's share price for today is ₹177.36.
QMS Medical Allied Services's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5.727.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QMSMEDI vs ISRG, BDX, RMD: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, QMS Medical Allied Services's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QMS Medical Allied Services EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QMS Medical Allied Services's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where QMS Medical Allied Services's EV-to-EBITDA falls into.
QMS Medical Allied Services's current Enterprise Value is ₹4,206 Mil.
QMS Medical Allied Services's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹289 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QMS Medical Allied Services (NSE:QMSMEDI) has a EV-to-EBITDA of 14.55 as of Sep. 21, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on QMS Medical Allied Services. This is 24% above median its historical median of 11.77. Over the past decade, QMS Medical Allied Services' EV-to-EBITDA has ranged from 3.40 to 84.01. According to the industry distribution chart, QMS Medical Allied Services ranks #289 out of 532 companies in the Medical Devices & Instruments industry, placing it in the top 54.3%.
Is QMS Medical Allied Services' EV-to-EBITDA too high?
QMS Medical Allied Services' current EV-to-EBITDA of 14.55 is 24% above median its 10-year median of 11.77. Over the past 10 years, this metric has ranged from a low of 3.40 to a high of 84.01. The Medical Devices & Instruments industry median EV-to-EBITDA is 13.14. QMS Medical Allied Services' value of 14.55 is 10.7% above this industry median. Based on the distribution chart, QMS Medical Allied Services ranks #289 out of 532 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, QMS Medical Allied Services has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does QMS Medical Allied Services' EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, QMS Medical Allied Services ranks #289 out of 532 companies for EV-to-EBITDA. This places QMS Medical Allied Services in the lower half of its industry. The industry median EV-to-EBITDA is 13.14. QMS Medical Allied Services' value of 14.55 is 10.7% above this benchmark. Historically, QMS Medical Allied Services' own EV-to-EBITDA has ranged from 3.40 to 84.01 over the past decade. While the company's 10-year median is 11.77 vs. the industry median of 13.14, QMS Medical Allied Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 13.14, based on 532 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QMS Medical Allied Services's current EV-to-EBITDA of 14.55 is 10.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on QMS Medical Allied Services. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 13.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QMS Medical Allied Services's current EV-to-EBITDA is 14.55, which is 24% above median its own 10-year median of 11.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QMS Medical Allied Services stock overvalued right now?
Based on GuruFocus' analysis, QMS Medical Allied Services (NSE:QMSMEDI) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹85.48, compared to a current price of ₹177.36 — trading 107.5% above its estimated fair value. The current EV-to-EBITDA is 14.55, which is 24% above median its 10-year median of 11.77 and 10.7% above the Medical Devices & Instruments industry median of 13.14. QMS Medical Allied Services' overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For QMS Medical Allied Services (NSE:QMSMEDI), the current EV-to-EBITDA is 14.55 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is QMS Medical Allied Services (NSE:QMSMEDI) Overvalued in 2026?
Based on GuruFocus' analysis, QMS Medical Allied Services stock appears to be overvalued.
The current stock price of ₹177.36 is trading 107.5% above its estimated GF Value™ of ₹85.48.
GuruFocus considers QMS Medical Allied Services to be Significantly Overvalued.
Key valuation signals for NSE:QMSMEDI:
EV-to-EBITDA: 14.55 (24% above median its 10-year median of 11.77)
GF Value™: ₹85.48 vs. price of ₹177.36 (107.5% above fair value)
Industry Position: 10.7% above the Medical Devices & Instruments median (#289 of 532)
No single metric tells the full story. See the NSE:QMSMEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
69GF Score
Get the complete analysis for NSE:QMSMEDI
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QMSMEDI has been successfully added to your 
